The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2 trial of pepinemab plus avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma.
 
Luis I. Ruffolo
No Relationships to Disclose
 
Terrence Lee Fisher
Employment - Vaccinex
Stock and Other Ownership Interests - Vaccinex
Patents, Royalties, Other Intellectual Property - Patent author, Vaccinex, Inc.
 
Elizabeth E. Evans
Employment - Vaccinex
Leadership - Vaccinex
Stock and Other Ownership Interests - Vaccinex
Honoraria - University of Rochester
Patents, Royalties, Other Intellectual Property - Inventor on following patents: Treatment of cancer with a semaphorin-4d antibody in combination with an epigenetic modulating agent. U.S. Provisional Patent Application No. 62/473,731 Use of Semaphorin-4D inhibitory molecules in combination with an im (Inst)
 
Crystal L. Mallow
Employment - Vaccinex
Stock and Other Ownership Interests - Vaccinex (I)
Travel, Accommodations, Expenses - Vaccinex
 
Megan Boise
Employment - Vaccinex
Stock and Other Ownership Interests - Vaccinex
 
Amber Foster
Employment - Vaccinex
Stock and Other Ownership Interests - Vaccinex
 
John E. Leonard
Employment - Vaccinex
Leadership - Vaccinex
Stock and Other Ownership Interests - Vaccinex
Travel, Accommodations, Expenses - Vaccinex
 
Brian A. Belt
No Relationships to Disclose
 
Jen Jen Yeh
Stock and Other Ownership Interests - ABBVIE/ABBOTT; BeiGene; Bristol-Myers Squibb/Roche; Focal Medical, Inc.; Moderna Therapeutics; Tango Therapeutics; Zentalis
Consulting or Advisory Role - Focal Medical, Inc.
Patents, Royalties, Other Intellectual Property - DECODER App # 17,336,600; DECODER App # 17,336,600; In vitro analysis and capture of CTCs 9,952,212; Interventional Drug Delivery System 10,695,562; Methods and compositions for prognostic and/or diagnostics in pancreatic cancer 11,053,550; PurIST Application # 17,601,002
 
Maurice Zauderer
Employment - Vaccinex
Leadership - Vaccinex
Stock and Other Ownership Interests - Vaccinex
Patents, Royalties, Other Intellectual Property - inventor on several patents assigned to Vaccinex, Inc. No royalty or other direct financial interest in patent.
 
David Linehan
No Relationships to Disclose
 
Daniel Mulkerin
No Relationships to Disclose